The effects of betamethasone treatment on clinical and laboratory features of pregnant women with HELLP syndrome

Archives of Gynecology and Obstetrics

Volumn 280, Issue 1, 2009, Pages 65-70

  Ozer, Alev ^a   Kanat Pektas, Mine ^a,b   Ozer, Serdar ^a   Tapisiz, Omer Lutfi ^a   Zulfikaroglu, Ebru Emine ^a   Danisman, Nuri ^a  

^a Education Hospital   (Turkey)

^b Ertugrul Gazi Mah Kutlugun Sok   (Turkey)

Author keywords

Betamethasone; Corticosteroid; HELLP syndrome; Maternal morbidity; Preeclampsia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETAMETHASONE; FUROSEMIDE; LACTATE DEHYDROGENASE; NIFEDIPINE; PLACEBO; GLUCOCORTICOID;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HELLP SYNDROME; HEMATOLOGIC DISEASE; HEMOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; METABOLIC DISORDER; OLIGURIA; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; BLOOD; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; INTRAMUSCULAR DRUG ADMINISTRATION; NONPARAMETRIC TEST; PREGNANCY; PROSPECTIVE STUDY;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BETAMETHASONE; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; FEMALE; GLUCOCORTICOIDS; HELLP SYNDROME; HUMANS; INJECTIONS, INTRAMUSCULAR; L-LACTATE DEHYDROGENASE; PLATELET COUNT; PREGNANCY; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 67649669978     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-008-0865-3     Document Type: Article

References (18)

1. JM O'Brien DA Milligan JR Barton 2000 Impact of high-dose corticosteroid therapy for patients with HELLP syndrome Am J Obstet Gynecol 183 4 921 924 10.1067/mob.2000.108869
2. J Riddell 4th CE Chenoweth CA Kauffman 2004 Disseminated Scedosporium apiospermum infection in a previously healthy woman with HELLP syndrome Mycoses 47 9-10 442 446 10.1111/j.1439-0507.2004.01015.x
3. EF Magann JN Martin Jr 1995 Complicated postpartum preeclampsia-eclampsia Obstet Gynecol Clin North Am 22 2 337 356
4. JN Martin Jr BD Thigpen CH Rose J Cushman A Moore WL May 2003 Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome Am J Obstet Gynecol 189 3 830 834 10.1067/S0002-9378(03)00763-4
5. Martin JN Jr, Magann EF, Isler CM (2003) HELLP syndrome: the scope of disease and treatment. Hypertens Pregnancy:141-188
6. EF Magann RW Martin JD Isaacs PG Blake JC Morrison JN Martin Jr 1993 Corticosteroids for the enhancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome Aust N Z J Obstet Gynaecol 33 127 131 10.1111/j.1479-828X.1993.tb02374.x (Pubitemid 23161990)
7. EF Magann DD Bass SP Chauhan DL Sullivan RW Martin JN Martin Jr 1994 Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes and, low platelets (HELLP) Am J Obstet Gynecol 171 1148 1153 (Pubitemid 24341516)
8. EF Magann KG Perry Jr EF Meydrech RL Harris SP Chauhan JN Martin 1994 Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) Am J Obstet Gynecol 171 1154 1158 (Pubitemid 24341517)
9. Vigil-De Gracia P, Garcia-Caceres E (1997) Dexamethasone in the post-partum treatment of HELLP syndrome. Int J Gynecol Obstet 59:217-221. 12 (Pubitemid 28036949)
10. JN Martin Jr KG Perry PG Blake WA May A Moore L Robinette 1997 Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP syndrome Am J Obstet Gynecol 177 1011 1017 10.1016/S0002-9378(97)70005-X
11. OT Yalcin T Sener H Hassa S Ozalp A Okur 1998 Effects of postpartum corticosteroids in patients with HELLP syndrome Int J Gynaecol Obstet 61 141 148 10.1016/S0020-7292(98)00036-8
12. F Varol T Aydin F Gucer 2001 HELLP syndrome and postpartum corticosteroids Int J Gynaecol Obstet 73 157 159 10.1016/S0020-7292(00)00371-4
13. CM Isler EF Magann BK Rinehart DA Terrone JD Bass JN Martin Jr 2003 Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome Int J Gynaecol Obstet 80 291 297 10.1016/S0020- 7292(02)00394-6
14. CH Rose BD Thigpen JA Bofill J Cushman WL May JN Martin Jr 2004 Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome Am J Obstet Gynecol 105 5 1011 1014 (Pubitemid 40458765)
15. JE Fonseca F Méndez C Cataño F Arias 2005 Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial Am J Obstet Gynecol 193 1591 1598 10.1016/j.ajog.2005.07.037
16. JN Martin Jr BK Rinehart WL May EF Magann DA Terrone PG Blake 1999 The spectrum of severe preeclampsia: comparative analysis by HELLP syndrome classification Am J Obstet Gynecol 180 1373 1384 10.1016/S0002-9378(99)70022-0
17. JM Tompkins S Thiagarajah 1999 HELLP (hemolysis, elevated liver enzymes, and low platelet) syndrome: the benefit of corticosteroids Am J Obstet Gynecol 181 304 309 10.1016/S0002-9378(99)70552-1
18. JM O'Brien SA Schumate SL Satchwell DA Milligan JR Barton 2002 Maternal benefit of corticosteroid therapy in patients with HELLP syndrome: impact on rate of regional anesthesia Am J Obstet Gynecol 186 475 479 10.1067/mob.2002. 121074